{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T14:49:12Z","timestamp":1764600552737,"version":"3.46.0"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"DOI":"10.7759\/cureus.98237","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T14:46:18Z","timestamp":1764600378000},"source":"Crossref","is-referenced-by-count":0,"title":["Insights From a Scoping Review and Bibliometric Analysis of Trends and Advances in Biomarker Research: The Role of MicroRNAs in Cognitive Decline Across Neurodegenerative Diseases"],"prefix":"10.7759","author":[{"given":"Samuel","family":"Reyes-Long","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto","family":"Roldan-Valadez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose-Luis","family":"Cortes-Altamirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Clavijo-Cornejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Alfaro-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2014.112","article-title":"The complexity of miRNA-mediated repression","volume":"22","author":"Wilczynska A","year":"2015","unstructured":"Wilczynska A, Bushell M. The complexity of miRNA-mediated repression. Cell Death Differ. 2015, 22:22-33. 10.1038\/cdd.2014.112","journal-title":"Cell Death Differ"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1159\/000323919","article-title":"MicroRNAs in oligodendrocyte and Schwann cell differentiation","volume":"33","author":"Dugas JC","year":"2011","unstructured":"Dugas JC, Notterpek L. MicroRNAs in oligodendrocyte and Schwann cell differentiation. Dev Neurosci. 2011, 33:14-20. 10.1159\/000323919","journal-title":"Dev Neurosci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/papr.12817","article-title":"microRNAs as biomarkers of pain intensity in patients with chronic fatigue syndrome","volume":"19","author":"Al-Rawaf HA","year":"2019","unstructured":"Al-Rawaf HA, Alghadir AH, Gabr SA. microRNAs as biomarkers of pain intensity in patients with chronic fatigue syndrome. Pain Pract. 2019, 19:848-60. 10.1111\/papr.12817","journal-title":"Pain Pract"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043574","article-title":"Role of the microRNAs in the pathogenic mechanism of painful symptoms in long COVID: systematic review","volume":"24","author":"Reyes-Long S","year":"2023","unstructured":"Reyes-Long S, Cort\u00e9s-Altamirano JL, Bandala C, et al.. Role of the microRNAs in the pathogenic mechanism of painful symptoms in long COVID: systematic review. Int J Mol Sci. 2023, 24:10.3390\/ijms24043574","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2020.135230","article-title":"The role of microRNAs in neurons and neuroimmune communication in the dorsal root ganglia in chronic pain","volume":"735","author":"Montague-Cardoso K","year":"2020","unstructured":"Montague-Cardoso K, Malcangio M. The role of microRNAs in neurons and neuroimmune communication in the dorsal root ganglia in chronic pain. Neurosci Lett. 2020, 735:135230. 10.1016\/j.neulet.2020.135230","journal-title":"Neurosci Lett"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2012.02.016","article-title":"MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction","volume":"46","author":"Xu B","year":"2012","unstructured":"Xu B, Hsu PK, Karayiorgou M, Gogos JA. MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction. Neurobiol Dis. 2012, 46:291-301. 10.1016\/j.nbd.2012.02.016","journal-title":"Neurobiol Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1017\/S1355617711000531","article-title":"Late-life social activity and cognitive decline in old age","volume":"17","author":"James BD","year":"2011","unstructured":"James BD, Wilson RS, Barnes LL, Bennett DA. Late-life social activity and cognitive decline in old age. J Int Neuropsychol Soc. 2011, 17:998-1005. 10.1017\/S1355617711000531","journal-title":"J Int Neuropsychol Soc"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12362","article-title":"Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020-2060)","volume":"17","author":"Rajan KB","year":"2021","unstructured":"Rajan KB, Weuve J, Barnes LL, McAninch EA, Wilson RS, Evans DA. Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020-2060). Alzheimers Dement. 2021, 17:1966-75. 10.1002\/alz.12362","journal-title":"Alzheimers Dement"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27902","article-title":"Prevalence and clinical aspects of mild cognitive impairment in Parkinson's disease: a meta-analysis","volume":"35","author":"Baiano C","year":"2020","unstructured":"Baiano C, Barone P, Trojano L, Santangelo G. Prevalence and clinical aspects of mild cognitive impairment in Parkinson's disease: a meta-analysis. Mov Disord. 2020, 35:45-54. 10.1002\/mds.27902","journal-title":"Mov Disord"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.335832","article-title":"Emerging blood exosome-based biomarkers for preclinical and clinical Alzheimer's disease: a meta-analysis and systematic review","volume":"17","author":"Liu WL","year":"2022","unstructured":"Liu WL, Lin HW, Lin MR, et al.. Emerging blood exosome-based biomarkers for preclinical and clinical Alzheimer's disease: a meta-analysis and systematic review. Neural Regen Res. 2022, 17:2381-90. 10.4103\/1673-5374.335832","journal-title":"Neural Regen Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-015-0555-z","article-title":"Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNF\u03b1","volume":"17","author":"Castro-Villegas C","year":"2015","unstructured":"Castro-Villegas C, P\u00e9rez-S\u00e1nchez C, Escudero A, et al.. Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNF\u03b1. Arthritis Res Ther. 2015, 17:49. 10.1186\/s13075-015-0555-z","journal-title":"Arthritis Res Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.nrl.2021.06.005","article-title":"The miRNA neuroinflammatory biomarkers in COVID-19 patients with different severity of illness","volume":"38","author":"Keikha R","year":"2023","unstructured":"Keikha R, Hashemi-Shahri SM, Jebali A. The miRNA neuroinflammatory biomarkers in COVID-19 patients with different severity of illness. Neurologia. 2023, 38:e41-51. 10.1016\/j.nrl.2021.06.005","journal-title":"Neurologia"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-018-0006-9","article-title":"miRNAs reshape immunity and inflammatory responses in bacterial infection","volume":"3","author":"Zhou X","year":"2018","unstructured":"Zhou X, Li X, Wu M. miRNAs reshape immunity and inflammatory responses in bacterial infection. Signal Transduct Target Ther. 2018, 3:14. 10.1038\/s41392-018-0006-9","journal-title":"Signal Transduct Target Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.1037068","article-title":"Bibliometric analysis of research on Alzheimer's disease and non-coding RNAs: opportunities and challenges","volume":"14","author":"Fei X","year":"2022","unstructured":"Fei X, Wang S, Li J, Zeng Q, Gao Y, Hu Y. Bibliometric analysis of research on Alzheimer's disease and non-coding RNAs: opportunities and challenges. Front Aging Neurosci. 2022, 14:1037068. 10.3389\/fnagi.2022.1037068","journal-title":"Front Aging Neurosci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25189936","article-title":"Insights into the role of microRNAs as clinical tools for diagnosis, prognosis, and as therapeutic targets in Alzheimer\u2019s disease","volume":"25","author":"Puranik N","year":"2024","unstructured":"Puranik N, Song M. Insights into the role of microRNAs as clinical tools for diagnosis, prognosis, and as therapeutic targets in Alzheimer\u2019s disease. Int J Mol Sci. 2024, 25:10.3390\/ijms25189936","journal-title":"Int J Mol Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-43096-9","article-title":"MicroRNAs in Parkinson's disease: a systematic review and diagnostic accuracy meta-analysis","volume":"13","author":"Gu\u00e9vremont D","year":"2023","unstructured":"Gu\u00e9vremont D, Roy J, Cutfield NJ, Williams JM. MicroRNAs in Parkinson's disease: a systematic review and diagnostic accuracy meta-analysis. Sci Rep. 2023, 13:16272. 10.1038\/s41598-023-43096-9","journal-title":"Sci Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13055","article-title":"MicroRNA expression in extracellular vesicles as a novel blood-based biomarker for Alzheimer's disease","volume":"19","author":"Kumar A","year":"2023","unstructured":"Kumar A, Su Y, Sharma M, et al.. MicroRNA expression in extracellular vesicles as a novel blood-based biomarker for Alzheimer's disease. Alzheimers Dement. 2023, 19:4952-66. 10.1002\/alz.13055","journal-title":"Alzheimers Dement"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.34133\/research.0114","article-title":"Plasma extracellular vesicle microRNA analysis of Alzheimer\u2019s disease reveals dysfunction of a neural correlation network","volume":"6","author":"Sun Y","year":"2023","unstructured":"Sun Y, Hefu Z, Li B, et al.. Plasma extracellular vesicle microRNA analysis of Alzheimer\u2019s disease reveals dysfunction of a neural correlation network. Research (Wash D C). 2023, 6:0114. 10.34133\/research.0114","journal-title":"Research (Wash D C)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14197","article-title":"Blood-derived microRNAs are related to cognitive domains in the general population","volume":"20","author":"Melas K","year":"2024","unstructured":"Melas K, Talevi V, Imtiaz MA, et al.. Blood-derived microRNAs are related to cognitive domains in the general population. Alzheimers Dement. 2024, 20:7138-59. 10.1002\/alz.14197","journal-title":"Alzheimers Dement"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-023-01366-8","article-title":"miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer's disease","volume":"16","author":"Han SW","year":"2024","unstructured":"Han SW, Pyun JM, Bice PJ, et al.. miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer's disease. Alzheimers Res Ther. 2024, 16:5. 10.1186\/s13195-023-01366-8","journal-title":"Alzheimers Res Ther"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-215502","article-title":"Alzheimer\u2019s disease diagnostics using miRNA biomarkers and machine learning","volume":"86","author":"Xu A","year":"2022","unstructured":"Xu A, Kouznetsova VL, Tsigelny IF. Alzheimer\u2019s disease diagnostics using miRNA biomarkers and machine learning. J Alzheimers Dis. 2022, 86:841-59. 10.3233\/JAD-215502","journal-title":"J Alzheimers Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2024.1385675","article-title":"Systematic genome-wide Mendelian randomization reveals the causal links between miRNAs and Parkinson's disease","volume":"18","author":"Shi G","year":"2024","unstructured":"Shi G, Wu T, Li X, Zhao D, Yin Q, Zhu L. Systematic genome-wide Mendelian randomization reveals the causal links between miRNAs and Parkinson's disease. Front Neurosci. 2024, 18:1385675. 10.3389\/fnins.2024.1385675","journal-title":"Front Neurosci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco AC","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, et al.. PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018, 169:467-73. 10.7326\/M18-0850","journal-title":"Ann Intern Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1177\/02537176221103617","article-title":"Bibliometric analysis for medical research","volume":"45","author":"Manoj Kumar L","year":"2023","unstructured":"Manoj Kumar L, George RJ. Bibliometric analysis for medical research. Indian J Psychol Med. 2023, 45:277-82. 10.1177\/02537176221103617","journal-title":"Indian J Psychol Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbusres.2021.04.070","article-title":"How to conduct a bibliometric analysis: an overview and guidelines","volume":"133","author":"Donthu N","year":"2021","unstructured":"Donthu N, Kumar S, Mukherjee D, et al.. How to conduct a bibliometric analysis: an overview and guidelines. J Bus Res. 2021, 133:285-96. 10.1016\/j.jbusres.2021.04.070","journal-title":"J Bus Res"},{"key":"ref26","doi-asserted-by":"crossref","DOI":"10.1001\/jama.1987.03390010056028","article-title":"100 citation classics from the Journal of the American Medical Association","volume":"257","author":"Garfield E","year":"1987","unstructured":"Garfield E. 100 citation classics from the Journal of the American Medical Association. JAMA. 1987, 257:52-9.","journal-title":"JAMA"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-018-1936-5","article-title":"Current concepts on bibliometrics: a brief review about impact factor, Eigenfactor score, CiteScore, SCImago Journal Rank, Source-Normalised Impact per Paper, H-index, and alternative metrics","volume":"188","author":"Roldan-Valadez E","year":"2019","unstructured":"Roldan-Valadez E, Salazar-Ruiz SY, Ibarra-Contreras R, Rios C. Current concepts on bibliometrics: a brief review about impact factor, Eigenfactor score, CiteScore, SCImago Journal Rank, Source-Normalised Impact per Paper, H-index, and alternative metrics. Ir J Med Sci. 2019, 188:939-51. 10.1007\/s11845-018-1936-5","journal-title":"Ir J Med Sci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-019-00996-z","article-title":"Impact factor correlations with Scimago Journal Rank, Source Normalized Impact per Paper, Eigenfactor Score, and the CiteScore in Radiology, Nuclear Medicine & Medical Imaging journals","volume":"124","author":"Villase\u00f1or-Almaraz M","year":"2019","unstructured":"Villase\u00f1or-Almaraz M, Islas-Serrano J, Murata C, Roldan-Valadez E. Impact factor correlations with Scimago Journal Rank, Source Normalized Impact per Paper, Eigenfactor Score, and the CiteScore in Radiology, Nuclear Medicine & Medical Imaging journals. Radiol Med. 2019, 124:495-504. 10.1007\/s11547-019-00996-z","journal-title":"Radiol Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.joi.2017.08.007","article-title":"bibliometrix: an R-tool for comprehensive science mapping analysis","volume":"11","author":"Aria MC","year":"2017","unstructured":"Aria MC. bibliometrix: an R-tool for comprehensive science mapping analysis. J Informetr. 2017, 11:959-75. 10.1016\/j.joi.2017.08.007","journal-title":"J Informetr"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: VOSviewer, a computer program for bibliometric mapping","volume":"84","author":"van Eck NJ","year":"2010","unstructured":"van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010, 84:523-38. 10.1007\/s11192-009-0146-3","journal-title":"Scientometrics"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2017.06.005","article-title":"Therapeutic miRNA and siRNA: moving from bench to clinic as next generation medicine","volume":"8","author":"Chakraborty C","year":"2017","unstructured":"Chakraborty C, Sharma AR, Sharma G, Doss CG, Lee SS. Therapeutic miRNA and siRNA: moving from bench to clinic as next generation medicine. Mol Ther Nucleic Acids. 2017, 8:132-43. 10.1016\/j.omtn.2017.06.005","journal-title":"Mol Ther Nucleic Acids"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-018-0791-7","article-title":"Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine","volume":"9","author":"Keshtkar S","year":"2018","unstructured":"Keshtkar S, Azarpira N, Ghahremani MH. Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine. Stem Cell Res Ther. 2018, 9:63. 10.1186\/s13287-018-0791-7","journal-title":"Stem Cell Res Ther"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.2741\/s415","article-title":"Parkinson's disease: a review","volume":"6","author":"Beitz JM","year":"2014","unstructured":"Beitz JM. Parkinson's disease: a review. Front Biosci (Schol Ed). 2014, 6:65-74. 10.2741\/s415","journal-title":"Front Biosci (Schol Ed)"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-017-0779-7","article-title":"Post-stroke dementia - a comprehensive review","volume":"15","author":"Mijajlovi\u0107 MD","year":"2017","unstructured":"Mijajlovi\u0107 MD, Pavlovi\u0107 A, Brainin M, et al.. Post-stroke dementia - a comprehensive review. BMC Med. 2017, 15:11. 10.1186\/s12916-017-0779-7","journal-title":"BMC Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.6158","article-title":"Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease","volume":"6","author":"Gui Y","year":"2015","unstructured":"Gui Y, Liu H, Zhang L, Lv W, Hu X. Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease. Oncotarget. 2015, 6:37043-53. 10.18632\/oncotarget.6158","journal-title":"Oncotarget"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2014.11.013","article-title":"Stress-induced perinatal and transgenerational epigenetic programming of brain development and mental health","volume":"48","author":"Babenko O","year":"2015","unstructured":"Babenko O, Kovalchuk I, Metz GA. Stress-induced perinatal and transgenerational epigenetic programming of brain development and mental health. Neurosci Biobehav Rev. 2015, 48:70-91. 10.1016\/j.neubiorev.2014.11.013","journal-title":"Neurosci Biobehav Rev"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.7150\/thno.21234","article-title":"Exosomes from human umbilical cord blood accelerate cutaneous wound healing through miR-21-3p-mediated promotion of angiogenesis and fibroblast function","volume":"8","author":"Hu Y","year":"2018","unstructured":"Hu Y, Rao SS, Wang ZX, et al.. Exosomes from human umbilical cord blood accelerate cutaneous wound healing through miR-21-3p-mediated promotion of angiogenesis and fibroblast function. Theranostics. 2018, 8:169-84. 10.7150\/thno.21234","journal-title":"Theranostics"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2020.02.001","article-title":"The \u03b2-secretase BACE1 in Alzheimer's disease","volume":"89","author":"Hampel H","year":"2021","unstructured":"Hampel H, Vassar R, De Strooper B, et al.. The \u03b2-secretase BACE1 in Alzheimer's disease. Biol Psychiatry. 2021, 89:745-56. 10.1016\/j.biopsych.2020.02.001","journal-title":"Biol Psychiatry"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00012.2013","article-title":"Dendritic spines: the locus of structural and functional plasticity","volume":"94","author":"Sala C","year":"2014","unstructured":"Sala C, Segal M. Dendritic spines: the locus of structural and functional plasticity. Physiol Rev. 2014, 94:141-88. 10.1152\/physrev.00012.2013","journal-title":"Physiol Rev"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00612","article-title":"Parkinson\u2019s disease: biomarkers, treatment, and risk factors","volume":"12","author":"Emamzadeh FN","year":"2018","unstructured":"Emamzadeh FN, Surguchov A. Parkinson\u2019s disease: biomarkers, treatment, and risk factors. Front Neurosci. 2018, 12:612. 10.3389\/fnins.2018.00612","journal-title":"Front Neurosci"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2014.00023","article-title":"Common features of microRNA target prediction tools","volume":"5","author":"Peterson SM","year":"2014","unstructured":"Peterson SM, Thompson JA, Ufkin ML, Sathyanarayana P, Liaw L, Congdon CB. Common features of microRNA target prediction tools. Front Genet. 2014, 5:23. 10.3389\/fgene.2014.00023","journal-title":"Front Genet"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1080\/14737159.2018.1428089","article-title":"An update on diagnostic and prognostic biomarkers for traumatic brain injury","volume":"18","author":"Wang KK","year":"2018","unstructured":"Wang KK, Yang Z, Zhu T, Shi Y, Rubenstein R, Tyndall JA, Manley GT. An update on diagnostic and prognostic biomarkers for traumatic brain injury. Expert Rev Mol Diagn. 2018, 18:165-80. 10.1080\/14737159.2018.1428089","journal-title":"Expert Rev Mol Diagn"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139233","article-title":"Plasma exosomal miRNAs in persons with and without Alzheimer disease: altered expression and prospects for biomarkers","volume":"10","author":"Lugli G","year":"2015","unstructured":"Lugli G, Cohen AM, Bennett DA, Shah RC, Fields CJ, Hernandez AG, Smalheiser NR. Plasma exosomal miRNAs in persons with and without Alzheimer disease: altered expression and prospects for biomarkers. PLoS One. 2015, 10:e0139233. 10.1371\/journal.pone.0139233","journal-title":"PLoS One"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2014.127","article-title":"Prognostic serum miRNA biomarkers associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessment","volume":"20","author":"Cheng L","year":"2015","unstructured":"Cheng L, Doecke JD, Sharples RA, et al.. Prognostic serum miRNA biomarkers associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessment. Mol Psychiatry. 2015, 20:1188-96. 10.1038\/mp.2014.127","journal-title":"Mol Psychiatry"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2388-4","article-title":"Reversing a model of Parkinson's disease with in situ converted nigral neurons","volume":"582","author":"Qian H","year":"2020","unstructured":"Qian H, Kang X, Hu J, et al.. Reversing a model of Parkinson's disease with in situ converted nigral neurons. Nature. 2020, 582:550-6. 10.1038\/s41586-020-2388-4","journal-title":"Nature"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3390\/cells8050488","article-title":"Amyloid beta and phosphorylated tau-induced defective autophagy and mitophagy in Alzheimer\u2019s disease","volume":"8","author":"Reddy PH","year":"2019","unstructured":"Reddy PH, Oliver DM. Amyloid beta and phosphorylated tau-induced defective autophagy and mitophagy in Alzheimer\u2019s disease. Cells. 2019, 8:10.3390\/cells8050488","journal-title":"Cells"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2016.68","article-title":"Extracellular vesicles in neurodegenerative disease - pathogenesis to biomarkers","volume":"12","author":"Thompson AG","year":"2016","unstructured":"Thompson AG, Gray E, Heman-Ackah SM, et al.. Extracellular vesicles in neurodegenerative disease - pathogenesis to biomarkers. Nat Rev Neurol. 2016, 12:346-57. 10.1038\/nrneurol.2016.68","journal-title":"Nat Rev Neurol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2015.05.002","article-title":"The epigenetics of aging and neurodegeneration","volume":"131","author":"Lardenoije R","year":"2015","unstructured":"Lardenoije R, Iatrou A, Kenis G, et al.. The epigenetics of aging and neurodegeneration. Prog Neurobiol. 2015, 131:21-64. 10.1016\/j.pneurobio.2015.05.002","journal-title":"Prog Neurobiol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2019.101664","article-title":"microRNA dysregulation in neurodegenerative diseases: a systematic review","volume":"182","author":"Ju\u017awik CA","year":"2019","unstructured":"Ju\u017awik CA, S Drake S, Zhang Y, et al.. microRNA dysregulation in neurodegenerative diseases: a systematic review. Prog Neurobiol. 2019, 182:101664. 10.1016\/j.pneurobio.2019.101664","journal-title":"Prog Neurobiol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-013-8544-1","article-title":"Exosomes: mediators of neurodegeneration, neuroprotection and therapeutics","volume":"49","author":"Kalani A","year":"2014","unstructured":"Kalani A, Tyagi A, Tyagi N. Exosomes: mediators of neurodegeneration, neuroprotection and therapeutics. Mol Neurobiol. 2014, 49:590-600. 10.1007\/s12035-013-8544-1","journal-title":"Mol Neurobiol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty333","article-title":"BNPMDA: Bipartite network projection for miRNA-Disease Association prediction","volume":"34","author":"Chen X","year":"2018","unstructured":"Chen X, Xie D, Wang L, Zhao Q, You ZH, Liu H. BNPMDA: Bipartite network projection for miRNA-Disease Association prediction. Bioinformatics. 2018, 34:3178-86. 10.1093\/bioinformatics\/bty333","journal-title":"Bioinformatics"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.3390\/genes7120116","article-title":"Deficiency in the ubiquitin conjugating enzyme UBE2A in Alzheimer's disease (AD) is linked to deficits in a natural circular miRNA-7 sponge (circRNA; ciRS-7)","volume":"7","author":"Zhao Y","year":"2016","unstructured":"Zhao Y, Alexandrov PN, Jaber V, Lukiw WJ. Deficiency in the ubiquitin conjugating enzyme UBE2A in Alzheimer's disease (AD) is linked to deficits in a natural circular miRNA-7 sponge (circRNA; ciRS-7). Genes (Basel). 2016, 7:10.3390\/genes7120116","journal-title":"Genes (Basel)"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-019-1500-y","article-title":"Systematic review of miRNA as biomarkers in Alzheimer's disease","volume":"56","author":"Swarbrick S","year":"2019","unstructured":"Swarbrick S, Wragg N, Ghosh S, Stolzing A. Systematic review of miRNA as biomarkers in Alzheimer's disease. Mol Neurobiol. 2019, 56:6156-67. 10.1007\/s12035-019-1500-y","journal-title":"Mol Neurobiol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2018.142","article-title":"A multi-omic atlas of the human frontal cortex for aging and Alzheimer's disease research","volume":"5","author":"De Jager PL","year":"2018","unstructured":"De Jager PL, Ma Y, McCabe C, et al.. A multi-omic atlas of the human frontal cortex for aging and Alzheimer's disease research. Sci Data. 2018, 5:180142. 10.1038\/sdata.2018.142","journal-title":"Sci Data"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2013.01.013","article-title":"The future of blood-based biomarkers for Alzheimer's disease","volume":"10","author":"Henriksen K","year":"2014","unstructured":"Henriksen K, O'Bryant SE, Hampel H, et al.. The future of blood-based biomarkers for Alzheimer's disease. Alzheimers Dement. 2014, 10:115-31. 10.1016\/j.jalz.2013.01.013","journal-title":"Alzheimers Dement"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201387576","article-title":"MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's disease","volume":"33","author":"Banzhaf-Strathmann J","year":"2014","unstructured":"Banzhaf-Strathmann J, Benito E, May S, et al.. MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's disease. EMBO J. 2014, 33:1667-80. 10.15252\/embj.201387576","journal-title":"EMBO J"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02622-3","article-title":"Mesenchymal stem cell derived-exosomes: a modern approach in translational medicine","volume":"18","author":"Nikfarjam S","year":"2020","unstructured":"Nikfarjam S, Rezaie J, Zolbanin NM, Jafari R. Mesenchymal stem cell derived-exosomes: a modern approach in translational medicine. J Transl Med. 2020, 18:449. 10.1186\/s12967-020-02622-3","journal-title":"J Transl Med"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094839","article-title":"Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology","volume":"9","author":"Burgos K","year":"2014","unstructured":"Burgos K, Malenica I, Metpally R, et al.. Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology. PLoS One. 2014, 9:e94839. 10.1371\/journal.pone.0094839","journal-title":"PLoS One"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2016.01.001","article-title":"Astrogliosis: an integral player in the pathogenesis of Alzheimer's disease","volume":"144","author":"Osborn LM","year":"2016","unstructured":"Osborn LM, Kamphuis W, Wadman WJ, Hol EM. Astrogliosis: an integral player in the pathogenesis of Alzheimer's disease. Prog Neurobiol. 2016, 144:121-41. 10.1016\/j.pneurobio.2016.01.001","journal-title":"Prog Neurobiol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2018.110","article-title":"Gene therapy for neurological disorders: progress and prospects","volume":"17","author":"Deverman BE","year":"2018","unstructured":"Deverman BE, Ravina BM, Bankiewicz KS, Paul SM, Sah DW. Gene therapy for neurological disorders: progress and prospects. Nat Rev Drug Discov. 2018, 17:641-59. 10.1038\/nrd.2018.110","journal-title":"Nat Rev Drug Discov"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01416","article-title":"Crosstalk between astrocytes and microglia: an overview","volume":"11","author":"Matejuk A","year":"2020","unstructured":"Matejuk A, Ransohoff RM. Crosstalk between astrocytes and microglia: an overview. Front Immunol. 2020, 11:1416. 10.3389\/fimmu.2020.01416","journal-title":"Front Immunol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2016.06.001","article-title":"Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?","volume":"1862","author":"Kumar S","year":"2016","unstructured":"Kumar S, Reddy PH. Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?. Biochim Biophys Acta. 2016, 1862:1617-27. 10.1016\/j.bbadis.2016.06.001","journal-title":"Biochim Biophys Acta"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-019-0501-5","article-title":"An atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associations","volume":"22","author":"Dube U","year":"2019","unstructured":"Dube U, Del-Aguila JL, Li Z, et al.. An atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associations. Nat Neurosci. 2019, 22:1903-12. 10.1038\/s41593-019-0501-5","journal-title":"Nat Neurosci"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17020171","article-title":"Focus on extracellular vesicles: physiological role and signalling properties of extracellular membrane vesicles","volume":"17","author":"Iraci N","year":"2016","unstructured":"Iraci N, Leonardi T, Gessler F, Vega B, Pluchino S. Focus on extracellular vesicles: physiological role and signalling properties of extracellular membrane vesicles. Int J Mol Sci. 2016, 17:171. 10.3390\/ijms17020171","journal-title":"Int J Mol Sci"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-130932","article-title":"MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer's disease","volume":"39","author":"Kiko T","year":"2014","unstructured":"Kiko T, Nakagawa K, Tsuduki T, Furukawa K, Arai H, Miyazawa T. MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer's disease. J Alzheimers Dis. 2014, 39:253-9. 10.3233\/JAD-130932","journal-title":"J Alzheimers Dis"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.355","article-title":"lncRNA\/MicroRNA interactions in the vasculature","volume":"99","author":"Ballantyne MD","year":"2016","unstructured":"Ballantyne MD, McDonald RA, Baker AH. lncRNA\/MicroRNA interactions in the vasculature. Clin Pharmacol Ther. 2016, 99:494-501. 10.1002\/cpt.355","journal-title":"Clin Pharmacol Ther"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2017.04.010","article-title":"Antisense oligonucleotides: translation from mouse models to human neurodegenerative diseases","volume":"94","author":"Schoch KM","year":"2017","unstructured":"Schoch KM, Miller TM. Antisense oligonucleotides: translation from mouse models to human neurodegenerative diseases. Neuron. 2017, 94:1056-70. 10.1016\/j.neuron.2017.04.010","journal-title":"Neuron"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3258-14.2014","article-title":"Emerging roles of extracellular vesicles in the nervous system","volume":"34","author":"Rajendran L","year":"2014","unstructured":"Rajendran L, Bali J, Barr MM, et al.. Emerging roles of extracellular vesicles in the nervous system. J Neurosci. 2014, 34:15482-9. 10.1523\/JNEUROSCI.3258-14.2014","journal-title":"J Neurosci"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2013.07.005","article-title":"MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid","volume":"35","author":"M\u00fcller M","year":"2014","unstructured":"M\u00fcller M, Kuiperij HB, Claassen JA, K\u00fcsters B, Verbeek MM. MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid. Neurobiol Aging. 2014, 35:152-8. 10.1016\/j.neurobiolaging.2013.07.005","journal-title":"Neurobiol Aging"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-014-9054-5","article-title":"Exosomes as a nanodelivery system: a key to the future of neuromedicine?","volume":"53","author":"Aryani A","year":"2016","unstructured":"Aryani A, Denecke B. Exosomes as a nanodelivery system: a key to the future of neuromedicine?. Mol Neurobiol. 2016, 53:818-34. 10.1007\/s12035-014-9054-5","journal-title":"Mol Neurobiol"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2013.10.002","article-title":"Circulating miR-125b as a biomarker of Alzheimer's disease","volume":"336","author":"Tan L","year":"2014","unstructured":"Tan L, Yu JT, Liu QY, et al.. Circulating miR-125b as a biomarker of Alzheimer's disease. J Neurol Sci. 2014, 336:52-6. 10.1016\/j.jns.2013.10.002","journal-title":"J Neurol Sci"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.3967\/bes2018.011","article-title":"The serum exosome derived microRNA-135a, -193b, and -384 were potential Alzheimer's disease biomarkers","volume":"31","author":"Yang TT","year":"2018","unstructured":"Yang TT, Liu CG, Gao SC, Zhang Y, Wang PC. The serum exosome derived microRNA-135a, -193b, and -384 were potential Alzheimer's disease biomarkers. Biomed Environ Sci. 2018, 31:87-96. 10.3967\/bes2018.011","journal-title":"Biomed Environ Sci"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126423","article-title":"MicroRNA profiling of CSF reveals potential biomarkers to detect Alzheimer's disease","volume":"10","author":"Denk J","year":"2015","unstructured":"Denk J, Boelmans K, Siegismund C, Lassner D, Arlt S, Jahn H. MicroRNA profiling of CSF reveals potential biomarkers to detect Alzheimer's disease. PLoS One. 2015, 10:e0126423. 10.1371\/journal.pone.0126423","journal-title":"PLoS One"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-132144","article-title":"Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease","volume":"40","author":"Tan L","year":"2014","unstructured":"Tan L, Yu JT, Tan MS, et al.. Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease. J Alzheimers Dis. 2014, 40:1017-27. 10.3233\/JAD-132144","journal-title":"J Alzheimers Dis"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17020173","article-title":"Focus on extracellular vesicles: exosomes and their role in protein trafficking and biomarker potential in Alzheimer\u2019s and Parkinson\u2019s disease","volume":"17","author":"Vella LJ","year":"2016","unstructured":"Vella LJ, Hill AF, Cheng L. Focus on extracellular vesicles: exosomes and their role in protein trafficking and biomarker potential in Alzheimer\u2019s and Parkinson\u2019s disease. Int J Mol Sci. 2016, 17:173. 10.3390\/ijms17020173","journal-title":"Int J Mol Sci"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-020-0696-0","article-title":"An integrated multi-omics approach identifies epigenetic alterations associated with Alzheimer's disease","volume":"52","author":"Nativio R","year":"2020","unstructured":"Nativio R, Lan Y, Donahue G, et al.. An integrated multi-omics approach identifies epigenetic alterations associated with Alzheimer's disease. Nat Genet. 2020, 52:1024-35. 10.1038\/s41588-020-0696-0","journal-title":"Nat Genet"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-140756","article-title":"Circulating miRNAs as potential biomarkers in Alzheimer's disease","volume":"42","author":"Galimberti D","year":"2014","unstructured":"Galimberti D, Villa C, Fenoglio C, et al.. Circulating miRNAs as potential biomarkers in Alzheimer's disease. J Alzheimers Dis. 2014, 42:1261-7. 10.3233\/JAD-140756","journal-title":"J Alzheimers Dis"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddv377","article-title":"miR-132\/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo","volume":"24","author":"Smith PY","year":"2015","unstructured":"Smith PY, Hernandez-Rapp J, Jolivette F, et al.. miR-132\/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo. Hum Mol Genet. 2015, 24:6721-35. 10.1093\/hmg\/ddv377","journal-title":"Hum Mol Genet"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-019-0448-1","article-title":"Blood-based molecular biomarkers for Alzheimer's disease","volume":"12","author":"Zetterberg H","year":"2019","unstructured":"Zetterberg H, Burnham SC. Blood-based molecular biomarkers for Alzheimer's disease. Mol Brain. 2019, 12:26. 10.1186\/s13041-019-0448-1","journal-title":"Mol Brain"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12267","article-title":"MiR-124 regulates apoptosis and autophagy process in MPTP model of Parkinson's disease by targeting to bim","volume":"26","author":"Wang H","year":"2016","unstructured":"Wang H, Ye Y, Zhu Z, et al.. MiR-124 regulates apoptosis and autophagy process in MPTP model of Parkinson's disease by targeting to bim. Brain Pathol. 2016, 26:167-76. 10.1111\/bpa.12267","journal-title":"Brain Pathol"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2019.101732","article-title":"Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders","volume":"185","author":"van den Berg MM","year":"2020","unstructured":"van den Berg MM, Krauskopf J, Ramaekers JG, Kleinjans JC, Prickaerts J, Bried\u00e9 JJ. Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders. Prog Neurobiol. 2020, 185:101732. 10.1016\/j.pneurobio.2019.101732","journal-title":"Prog Neurobiol"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2014.2484","article-title":"MicroRNA-193b is a regulator of amyloid precursor protein in the blood and cerebrospinal fluid derived exosomal microRNA-193b is a biomarker of Alzheimer's disease","volume":"10","author":"Liu CG","year":"2014","unstructured":"Liu CG, Song J, Zhang YQ, Wang PC. MicroRNA-193b is a regulator of amyloid precursor protein in the blood and cerebrospinal fluid derived exosomal microRNA-193b is a biomarker of Alzheimer's disease. Mol Med Rep. 2014, 10:2395-400. 10.3892\/mmr.2014.2484","journal-title":"Mol Med Rep"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/625659","article-title":"Serum microRNA profiles serve as novel biomarkers for the diagnosis of Alzheimer\u2019s disease","volume":"2015","author":"Dong H","year":"2015","unstructured":"Dong H, Li J, Huang L, et al.. Serum microRNA profiles serve as novel biomarkers for the diagnosis of Alzheimer\u2019s disease. Dis Markers. 2015, 2015:625659. 10.1155\/2015\/625659","journal-title":"Dis Markers"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1172\/JCI78421","article-title":"Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tau","volume":"125","author":"Santa-Maria I","year":"2015","unstructured":"Santa-Maria I, Alaniz ME, Renwick N, et al.. Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tau. J Clin Invest. 2015, 125:681-6. 10.1172\/JCI78421","journal-title":"J Clin Invest"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-016-0055-4","article-title":"Regulatory role of circular RNAs and neurological disorders","volume":"54","author":"Floris G","year":"2017","unstructured":"Floris G, Zhang L, Follesa P, Sun T. Regulatory role of circular RNAs and neurological disorders. Mol Neurobiol. 2017, 54:5156-65. 10.1007\/s12035-016-0055-4","journal-title":"Mol Neurobiol"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2017.07.023","article-title":"A novel microRNA-124\/PTPN1 signal pathway mediates synaptic and memory deficits in Alzheimer\u2019s disease","volume":"83","author":"Wang X","year":"2018","unstructured":"Wang X, Liu D, Huang HZ, et al.. A novel microRNA-124\/PTPN1 signal pathway mediates synaptic and memory deficits in Alzheimer\u2019s disease. Biol Psychiatry. 2018, 83:395-405. 10.1016\/j.biopsych.2017.07.023","journal-title":"Biol Psychiatry"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.518241","article-title":"MicroRNA-339-5p down-regulates protein expression of \u03b2-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects","volume":"289","author":"Long JM","year":"2014","unstructured":"Long JM, Ray B, Lahiri DK. MicroRNA-339-5p down-regulates protein expression of \u03b2-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects. J Biol Chem. 2014, 289:5184-98. 10.1074\/jbc.M113.518241","journal-title":"J Biol Chem"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2013.16","article-title":"Neurodevelopmental and neuropsychiatric disorders represent an interconnected molecular system","volume":"19","author":"Cristino AS","year":"2014","unstructured":"Cristino AS, Williams SM, Hawi Z, et al.. Neurodevelopmental and neuropsychiatric disorders represent an interconnected molecular system. Mol Psychiatry. 2014, 19:294-301. 10.1038\/mp.2013.16","journal-title":"Mol Psychiatry"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2017.02.045","article-title":"MicroRNA biomarkers of Parkinson's disease in serum exosome-like microvesicles","volume":"644","author":"Cao XY","year":"2017","unstructured":"Cao XY, Lu JM, Zhao ZQ, Li MC, Lu T, An XS, Xue LJ. MicroRNA biomarkers of Parkinson's disease in serum exosome-like microvesicles. Neurosci Lett. 2017, 644:94-9. 10.1016\/j.neulet.2017.02.045","journal-title":"Neurosci Lett"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.170019","article-title":"SNPs in microRNA target sites and their potential role in human disease","volume":"7","author":"Moszy\u0144ska A","year":"2017","unstructured":"Moszy\u0144ska A, Gebert M, Collawn JF, Bartoszewski R. SNPs in microRNA target sites and their potential role in human disease. Open Biol. 2017, 7:10.1098\/rsob.170019","journal-title":"Open Biol"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-020-00636-z","article-title":"Functional roles and networks of non-coding RNAs in the pathogenesis of neurodegenerative diseases","volume":"27","author":"Wu YY","year":"2020","unstructured":"Wu YY, Kuo HC. Functional roles and networks of non-coding RNAs in the pathogenesis of neurodegenerative diseases. J Biomed Sci. 2020, 27:49. 10.1186\/s12929-020-00636-z","journal-title":"J Biomed Sci"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2016.06.005","article-title":"MicroRNA-124 loaded nanoparticles enhance brain repair in Parkinson's disease","volume":"235","author":"Saraiva C","year":"2016","unstructured":"Saraiva C, Paiva J, Santos T, Ferreira L, Bernardino L. MicroRNA-124 loaded nanoparticles enhance brain repair in Parkinson's disease. J Control Release. 2016, 235:291-305. 10.1016\/j.jconrel.2016.06.005","journal-title":"J Control Release"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2014.12.014","article-title":"Inhibition of miR-34b and miR-34c enhances \u03b1-synuclein expression in Parkinson's disease","volume":"589","author":"Kabaria S","year":"2015","unstructured":"Kabaria S, Choi DC, Chaudhuri AD, Mouradian MM, Junn E. Inhibition of miR-34b and miR-34c enhances \u03b1-synuclein expression in Parkinson's disease. FEBS Lett. 2015, 589:319-25. 10.1016\/j.febslet.2014.12.014","journal-title":"FEBS Lett"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2014.00156","article-title":"Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and multiple system atrophy","volume":"8","author":"Vallelunga A","year":"2014","unstructured":"Vallelunga A, Ragusa M, Di Mauro S, et al.. Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and multiple system atrophy. Front Cell Neurosci. 2014, 8:156. 10.3389\/fncel.2014.00156","journal-title":"Front Cell Neurosci"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2016.05.026","article-title":"Expression of microRNA-34a in Alzheimer's disease brain targets genes linked to synaptic plasticity, energy metabolism, and resting state network activity","volume":"1646","author":"Sarkar S","year":"2016","unstructured":"Sarkar S, Jun S, Rellick S, Quintana DD, Cavendish JZ, Simpkins JW. Expression of microRNA-34a in Alzheimer's disease brain targets genes linked to synaptic plasticity, energy metabolism, and resting state network activity. Brain Res. 2016, 1646:139-51. 10.1016\/j.brainres.2016.05.026","journal-title":"Brain Res"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.4137\/BMI.S25132","article-title":"microRNA-seq data analysis pipeline to identify blood biomarkers for Alzheimer\u2019s disease from public data","volume":"10","author":"Satoh J","year":"2015","unstructured":"Satoh J, Kino Y, Niida S. microRNA-seq data analysis pipeline to identify blood biomarkers for Alzheimer\u2019s disease from public data. Biomark Insights. 2015, 10:21-31. 10.4137\/BMI.S25132","journal-title":"Biomark Insights"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2019.101694","article-title":"Exosomal miRNAs in central nervous system diseases: biomarkers, pathological mediators, protective factors and therapeutic agents","volume":"183","author":"Xia X","year":"2019","unstructured":"Xia X, Wang Y, Huang Y, Zhang H, Lu H, Zheng JC. Exosomal miRNAs in central nervous system diseases: biomarkers, pathological mediators, protective factors and therapeutic agents. Prog Neurobiol. 2019, 183:101694. 10.1016\/j.pneurobio.2019.101694","journal-title":"Prog Neurobiol"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2015.11.014","article-title":"Identification of a panel of five serum miRNAs as a biomarker for Parkinson's disease","volume":"22","author":"Ding H","year":"2016","unstructured":"Ding H, Huang Z, Chen M, Wang C, Chen X, Chen J, Zhang J. Identification of a panel of five serum miRNAs as a biomarker for Parkinson's disease. Parkinsonism Relat Disord. 2016, 22:68-73. 10.1016\/j.parkreldis.2015.11.014","journal-title":"Parkinsonism Relat Disord"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-014-1628-x","article-title":"miR-1, miR-10b, miR-155, and miR-191 are novel regulators of BDNF","volume":"71","author":"Varendi K","year":"2014","unstructured":"Varendi K, Kumar A, H\u00e4rma MA, Andressoo JO. miR-1, miR-10b, miR-155, and miR-191 are novel regulators of BDNF. Cell Mol Life Sci. 2014, 71:4443-56. 10.1007\/s00018-014-1628-x","journal-title":"Cell Mol Life Sci"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2013.08.003","article-title":"miR128 up-regulation correlates with impaired amyloid \u03b2(1-42) degradation in monocytes from patients with sporadic Alzheimer's disease","volume":"35","author":"Tiribuzi R","year":"2014","unstructured":"Tiribuzi R, Crispoltoni L, Porcellati S, et al.. miR128 up-regulation correlates with impaired amyloid \u03b2(1-42) degradation in monocytes from patients with sporadic Alzheimer's disease. Neurobiol Aging. 2014, 35:345-56. 10.1016\/j.neurobiolaging.2013.08.003","journal-title":"Neurobiol Aging"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2014.00113","article-title":"The role of extracellular Tau in the spreading of neurofibrillary pathology","volume":"8","author":"Medina M","year":"2014","unstructured":"Medina M, Avila J. The role of extracellular Tau in the spreading of neurofibrillary pathology. Front Cell Neurosci. 2014, 8:113. 10.3389\/fncel.2014.00113","journal-title":"Front Cell Neurosci"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-016-0053-5","article-title":"miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer's disease and other types of dementia - an exploratory study","volume":"5","author":"S\u00f8rensen SS","year":"2016","unstructured":"S\u00f8rensen SS, Nygaard AB, Christensen T. miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer's disease and other types of dementia - an exploratory study. Transl Neurodegener. 2016, 5:6. 10.1186\/s40035-016-0053-5","journal-title":"Transl Neurodegener"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-017-0414-z","article-title":"Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease","volume":"5","author":"Hara N","year":"2017","unstructured":"Hara N, Kikuchi M, Miyashita A, et al.. Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease. Acta Neuropathol Commun. 2017, 5:10. 10.1186\/s40478-017-0414-z","journal-title":"Acta Neuropathol Commun"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2014.01.021","article-title":"miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor\/phosphoinositide 3-kinase signaling","volume":"35","author":"Kim W","year":"2014","unstructured":"Kim W, Lee Y, McKenna ND, et al.. miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor\/phosphoinositide 3-kinase signaling. Neurobiol Aging. 2014, 35:1712-21. 10.1016\/j.neurobiolaging.2014.01.021","journal-title":"Neurobiol Aging"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.01208","article-title":"miR-212 and miR-132 are downregulated in neurally derived plasma exosomes of Alzheimer\u2019s patients","volume":"13","author":"Cha DJ","year":"2019","unstructured":"Cha DJ, Mengel D, Mustapic M, et al.. miR-212 and miR-132 are downregulated in neurally derived plasma exosomes of Alzheimer\u2019s patients. Front Neurosci. 2019, 13:1208. 10.3389\/fnins.2019.01208","journal-title":"Front Neurosci"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2014.00002","article-title":"Increased microRNA-34c abundance in Alzheimer's disease circulating blood plasma","volume":"7","author":"Bhatnagar S","year":"2014","unstructured":"Bhatnagar S, Chertkow H, Schipper HM, et al.. Increased microRNA-34c abundance in Alzheimer's disease circulating blood plasma. Front Mol Neurosci. 2014, 7:2. 10.3389\/fnmol.2014.00002","journal-title":"Front Mol Neurosci"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2016.00036","article-title":"microRNA profiles in Parkinson\u2019s disease prefrontal cortex","volume":"8","author":"Hoss AG","year":"2016","unstructured":"Hoss AG, Labadorf A, Beach TG, Latourelle JC, Myers RH. microRNA profiles in Parkinson\u2019s disease prefrontal cortex. Front Aging Neurosci. 2016, 8:36. 10.3389\/fnagi.2016.00036","journal-title":"Front Aging Neurosci"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddx267","article-title":"MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer's disease","volume":"26","author":"Kumar S","year":"2017","unstructured":"Kumar S, Vijayan M, Reddy PH. MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer's disease. Hum Mol Genet. 2017, 26:3808-22. 10.1093\/hmg\/ddx267","journal-title":"Hum Mol Genet"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00153","article-title":"MicroRNAs in Alzheimer's disease","volume":"10","author":"Wang M","year":"2019","unstructured":"Wang M, Qin L, Tang B. MicroRNAs in Alzheimer's disease. Front Genet. 2019, 10:153. 10.3389\/fgene.2019.00153","journal-title":"Front Genet"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-015-9156-8","article-title":"microRNA-29a is a candidate biomarker for Alzheimer\u2019s disease in cell-free cerebrospinal fluid","volume":"53","author":"M\u00fcller M","year":"2016","unstructured":"M\u00fcller M, J\u00e4kel L, Bruinsma IB, Claassen JA, Kuiperij HB, Verbeek MM. microRNA-29a is a candidate biomarker for Alzheimer\u2019s disease in cell-free cerebrospinal fluid. Mol Neurobiol. 2016, 53:2894-9. 10.1007\/s12035-015-9156-8","journal-title":"Mol Neurobiol"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-018-1032-x","article-title":"microRNA expression levels are altered in the cerebrospinal fluid of patients with young-onset Alzheimer\u2019s disease","volume":"55","author":"McKeever PM","year":"2018","unstructured":"McKeever PM, Schneider R, Taghdiri F, et al.. microRNA expression levels are altered in the cerebrospinal fluid of patients with young-onset Alzheimer\u2019s disease. Mol Neurobiol. 2018, 55:8826-41. 10.1007\/s12035-018-1032-x","journal-title":"Mol Neurobiol"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00076","article-title":"The aerobic and cognitive exercise study (ACES) for community-dwelling older adults with or at-risk for mild cognitive impairment (MCI): neuropsychological, neurobiological and neuroimaging outcomes of a randomized clinical trial","volume":"10","author":"Anderson-Hanley C","year":"2018","unstructured":"Anderson-Hanley C, Barcelos NM, Zimmerman EA, et al.. The aerobic and cognitive exercise study (ACES) for community-dwelling older adults with or at-risk for mild cognitive impairment (MCI): neuropsychological, neurobiological and neuroimaging outcomes of a randomized clinical trial. Front Aging Neurosci. 2018, 10:76. 10.3389\/fnagi.2018.00076","journal-title":"Front Aging Neurosci"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-161179","article-title":"microRNA profile in patients with Alzheimer\u2019s disease: analysis of miR-9-5p and miR-598 in raw and exosome enriched cerebrospinal fluid samples","volume":"57","author":"Riancho J","year":"2017","unstructured":"Riancho J, V\u00e1zquez-Higuera JL, Pozueta A, et al.. microRNA profile in patients with Alzheimer\u2019s disease: analysis of miR-9-5p and miR-598 in raw and exosome enriched cerebrospinal fluid samples. J Alzheimers Dis. 2017, 57:483-91. 10.3233\/JAD-161179","journal-title":"J Alzheimers Dis"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2018.03.004","article-title":"Salivary biomarkers for the diagnosis and\u00a0monitoring of neurological diseases","volume":"41","author":"Farah R","year":"2018","unstructured":"Farah R, Haraty H, Salame Z, Fares Y, Ojcius DM, Said Sadier N. Salivary biomarkers for the diagnosis and\u00a0monitoring of neurological diseases. Biomed J. 2018, 41:63-87. 10.1016\/j.bj.2018.03.004","journal-title":"Biomed J"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1421182112","article-title":"Na, K-ATPase \u03b13 is a death target of Alzheimer patient amyloid-\u03b2 assembly","volume":"112","author":"Ohnishi T","year":"2015","unstructured":"Ohnishi T, Yanazawa M, Sasahara T, et al.. Na, K-ATPase \u03b13 is a death target of Alzheimer patient amyloid-\u03b2 assembly. Proc Natl Acad Sci U S A. 2015, 112:E4465-74. 10.1073\/pnas.1421182112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1261\/rna.044008.113","article-title":"Brain-specific knockdown of miR-29 results in neuronal cell death and ataxia in mice","volume":"20","author":"Roshan R","year":"2014","unstructured":"Roshan R, Shridhar S, Sarangdhar MA, et al.. Brain-specific knockdown of miR-29 results in neuronal cell death and ataxia in mice. RNA. 2014, 20:1287-97. 10.1261\/rna.044008.113","journal-title":"RNA"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2013.0515","article-title":"MicroRNAs and synaptic plasticity--a mutual relationship","volume":"369","author":"Aksoy-Aksel A","year":"2014","unstructured":"Aksoy-Aksel A, Zampa F, Schratt G. MicroRNAs and synaptic plasticity--a mutual relationship. Philos Trans R Soc Lond B Biol Sci. 2014, 369:10.1098\/rstb.2013.0515","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1007\/s12264-019-00361-0","article-title":"Circular HDAC9\/microRNA-138\/sirtuin-1 pathway mediates synaptic and amyloid precursor protein processing deficits in Alzheimer\u2019s disease","volume":"35","author":"Lu Y","year":"2019","unstructured":"Lu Y, Tan L, Wang X. Circular HDAC9\/microRNA-138\/sirtuin-1 pathway mediates synaptic and amyloid precursor protein processing deficits in Alzheimer\u2019s disease. Neurosci Bull. 2019, 35:877-88. 10.1007\/s12264-019-00361-0","journal-title":"Neurosci Bull"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2014.00182","article-title":"miR-7 and miR-153 protect neurons against MPP(+)-induced cell death via upregulation of mTOR pathway","volume":"8","author":"Fragkouli A","year":"2014","unstructured":"Fragkouli A, Doxakis E. miR-7 and miR-153 protect neurons against MPP(+)-induced cell death via upregulation of mTOR pathway. Front Cell Neurosci. 2014, 8:182. 10.3389\/fncel.2014.00182","journal-title":"Front Cell Neurosci"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-016-0088-8","article-title":"Plasma miR-34a-5p and miR-545-3p as early biomarkers of Alzheimer\u2019s disease: potential and limitations","volume":"54","author":"Cos\u00edn-Tom\u00e1s M","year":"2017","unstructured":"Cos\u00edn-Tom\u00e1s M, Antonell A, Llad\u00f3 A, et al.. Plasma miR-34a-5p and miR-545-3p as early biomarkers of Alzheimer\u2019s disease: potential and limitations. Mol Neurobiol. 2017, 54:5550-62. 10.1007\/s12035-016-0088-8","journal-title":"Mol Neurobiol"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201606520","article-title":"miR-132 loss de-represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer's brain","volume":"8","author":"Salta E","year":"2016","unstructured":"Salta E, Sierksma A, Vanden Eynden E, De Strooper B. miR-132 loss de-represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer's brain. EMBO Mol Med. 2016, 8:1005-18. 10.15252\/emmm.201606520","journal-title":"EMBO Mol Med"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15109","article-title":"Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer's disease patients from non-demented subjects","volume":"8","author":"Nagaraj S","year":"2017","unstructured":"Nagaraj S, Laskowska-Kaszub K, D\u0119bski KJ, et al.. Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer's disease patients from non-demented subjects. Oncotarget. 2017, 8:16122-43. 10.18632\/oncotarget.15109","journal-title":"Oncotarget"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.23377","article-title":"Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease","volume":"92","author":"Botta-Orfila T","year":"2014","unstructured":"Botta-Orfila T, Morat\u00f3 X, Compta Y, et al.. Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease. J Neurosci Res. 2014, 92:1071-7. 10.1002\/jnr.23377","journal-title":"J Neurosci Res"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2017.02.014","article-title":"miRNAs in synapse development and synaptic plasticity","volume":"45","author":"Hu Z","year":"2017","unstructured":"Hu Z, Li Z. miRNAs in synapse development and synaptic plasticity. Curr Opin Neurobiol. 2017, 45:24-31. 10.1016\/j.conb.2017.02.014","journal-title":"Curr Opin Neurobiol"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2015.12.005","article-title":"Emergence of exosomal miRNAs as a diagnostic biomarker for Alzheimer's disease","volume":"360","author":"Van Giau V","year":"2016","unstructured":"Van Giau V, An SS. Emergence of exosomal miRNAs as a diagnostic biomarker for Alzheimer's disease. J Neurol Sci. 2016, 360:141-52. 10.1016\/j.jns.2015.12.005","journal-title":"J Neurol Sci"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-018-0266-3","article-title":"Novel upregulation of amyloid-\u03b2 precursor protein (APP) by microRNA-346 via targeting of APP mRNA 5'-untranslated region: implications in Alzheimer's disease","volume":"24","author":"Long JM","year":"2019","unstructured":"Long JM, Maloney B, Rogers JT, Lahiri DK. Novel upregulation of amyloid-\u03b2 precursor protein (APP) by microRNA-346 via targeting of APP mRNA 5'-untranslated region: implications in Alzheimer's disease. Mol Psychiatry. 2019, 24:345-63. 10.1038\/s41380-018-0266-3","journal-title":"Mol Psychiatry"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-019-0169-5","article-title":"Exploratory study on microRNA profiles from plasma-derived extracellular vesicles in Alzheimer's disease and dementia with Lewy bodies","volume":"8","author":"G\u00e1mez-Valero A","year":"2019","unstructured":"G\u00e1mez-Valero A, Campdelacreu J, Vilas D, et al.. Exploratory study on microRNA profiles from plasma-derived extracellular vesicles in Alzheimer's disease and dementia with Lewy bodies. Transl Neurodegener. 2019, 8:31. 10.1186\/s40035-019-0169-5","journal-title":"Transl Neurodegener"},{"key":"ref128","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2014.00005","article-title":"MicroRNAs in brain development and function: a matter of flexibility and stability","volume":"7","author":"Follert P","year":"2014","unstructured":"Follert P, Cremer H, B\u00e9clin C. MicroRNAs in brain development and function: a matter of flexibility and stability. Front Mol Neurosci. 2014, 7:5. 10.3389\/fnmol.2014.00005","journal-title":"Front Mol Neurosci"},{"key":"ref129","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1241010","article-title":"The role of exercise parameters on small extracellular vesicles and microRNAs cargo in preventing neurodegenerative diseases","volume":"14","author":"Fischetti F","year":"2023","unstructured":"Fischetti F, Poli L, De Tommaso M, Paolicelli D, Greco G, Cataldi S. The role of exercise parameters on small extracellular vesicles and microRNAs cargo in preventing neurodegenerative diseases. Front Physiol. 2023, 14:1241010. 10.3389\/fphys.2023.1241010","journal-title":"Front Physiol"},{"key":"ref130","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.410","article-title":"The emerging role of exosomes in communication between the periphery and the central nervous system","volume":"4","author":"Han W","year":"2023","unstructured":"Han W, Zhang H, Feng L, Dang R, Wang J, Cui C, Jiang P. The emerging role of exosomes in communication between the periphery and the central nervous system. MedComm (2020). 2023, 4:e410. 10.1002\/mco2.410","journal-title":"MedComm (2020)"},{"key":"ref131","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03359-2","article-title":"Delivering synaptic protein mRNAs via extracellular vesicles ameliorates cognitive impairment in a mouse model of Alzheimer's disease","volume":"22","author":"Cai H","year":"2024","unstructured":"Cai H, Pang Y, Ren Z, Fu X, Jia L. Delivering synaptic protein mRNAs via extracellular vesicles ameliorates cognitive impairment in a mouse model of Alzheimer's disease. BMC Med. 2024, 22:138. 10.1186\/s12916-024-03359-2","journal-title":"BMC Med"},{"key":"ref132","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2019.1703249","article-title":"Neuronal-derived extracellular vesicles are enriched in the brain and serum of HIV-1 transgenic rats","volume":"9","author":"Dagur RS","year":"2020","unstructured":"Dagur RS, Liao K, Sil S, et al.. Neuronal-derived extracellular vesicles are enriched in the brain and serum of HIV-1 transgenic rats. J Extracell Vesicles. 2020, 9:1703249. 10.1080\/20013078.2019.1703249","journal-title":"J Extracell Vesicles"},{"key":"ref133","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-18719-2","article-title":"Syntaxin-1a and SNAP-25 expression level is increased in the blood samples of ischemic stroke patients","volume":"12","author":"Cappelletti P","year":"2022","unstructured":"Cappelletti P, Filareti M, Masuelli L, Bei R, Hassanzadeh K, Corbo M, Feligioni M. Syntaxin-1a and SNAP-25 expression level is increased in the blood samples of ischemic stroke patients. Sci Rep. 2022, 12:14483. 10.1038\/s41598-022-18719-2","journal-title":"Sci Rep"},{"key":"ref134","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-022-01010-x","article-title":"\u03b2-Amyloid in blood neuronal-derived extracellular vesicles is elevated in cognitively normal adults at risk of Alzheimer's disease and predicts cerebral amyloidosis","volume":"14","author":"Li TR","year":"2022","unstructured":"Li TR, Yao YX, Jiang XY, et al.. \u03b2-Amyloid in blood neuronal-derived extracellular vesicles is elevated in cognitively normal adults at risk of Alzheimer's disease and predicts cerebral amyloidosis. Alzheimers Res Ther. 2022, 14:66. 10.1186\/s13195-022-01010-x","journal-title":"Alzheimers Res Ther"},{"key":"ref135","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12499","article-title":"Aberrant crosstalk between insulin signaling and mTOR in young Down syndrome individuals revealed by neuronal-derived extracellular vesicles","volume":"18","author":"Perluigi M","year":"2022","unstructured":"Perluigi M, Picca A, Montanari E, et al.. Aberrant crosstalk between insulin signaling and mTOR in young Down syndrome individuals revealed by neuronal-derived extracellular vesicles. Alzheimers Dement. 2022, 18:1498-510. 10.1002\/alz.12499","journal-title":"Alzheimers Dement"},{"key":"ref136","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-024-01576-9","article-title":"Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment","volume":"27","author":"Greene C","year":"2024","unstructured":"Greene C, Connolly R, Brennan D, et al.. Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat Neurosci. 2024, 27:421-32. 10.1038\/s41593-024-01576-9","journal-title":"Nat Neurosci"},{"key":"ref137","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-01806-3","article-title":"Brain microRNAs are associated with variation in cognitive trajectory in advanced age","volume":"12","author":"Wingo AP","year":"2022","unstructured":"Wingo AP, Wang M, Liu J, et al.. Brain microRNAs are associated with variation in cognitive trajectory in advanced age. Transl Psychiatry. 2022, 12:47. 10.1038\/s41398-022-01806-3","journal-title":"Transl Psychiatry"},{"key":"ref138","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-018-0859-7","article-title":"miR-320b is down-regulated in psoriasis and modulates keratinocyte proliferation by targeting AKT3","volume":"41","author":"Wang Y","year":"2018","unstructured":"Wang Y, Yu X, Wang L, Ma W, Sun Q. miR-320b is down-regulated in psoriasis and modulates keratinocyte proliferation by targeting AKT3. Inflammation. 2018, 41:2160-70. 10.1007\/s10753-018-0859-7","journal-title":"Inflammation"},{"key":"ref139","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14157","article-title":"The plasma miRNAome in ADNI: signatures to aid the detection of at-risk individuals","volume":"20","author":"Kr\u00fcger DM","year":"2024","unstructured":"Kr\u00fcger DM, Pena-Centeno T, Liu S, et al.. The plasma miRNAome in ADNI: signatures to aid the detection of at-risk individuals. Alzheimers Dement. 2024, 20:7479-94. 10.1002\/alz.14157","journal-title":"Alzheimers Dement"},{"key":"ref140","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063554","article-title":"Plasma miR-203a-3p as a novel predictor of dementia in patients with Parkinson\u2019s disease","volume":"25","author":"Hsu YF","year":"2024","unstructured":"Hsu YF, Lin SP, Chu YT, Tsai YT, Huang JW, Phoa FK, Wu RM. Plasma miR-203a-3p as a novel predictor of dementia in patients with Parkinson\u2019s disease. Int J Mol Sci. 2024, 25:10.3390\/ijms25063554","journal-title":"Int J Mol Sci"},{"key":"ref141","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1228927","article-title":"Common microRNA regulated pathways in Alzheimer's and Parkinson's disease","volume":"17","author":"Awuson-David B","year":"2023","unstructured":"Awuson-David B, Williams AC, Wright B, Hill LJ, Di Pietro V. Common microRNA regulated pathways in Alzheimer's and Parkinson's disease. Front Neurosci. 2023, 17:1228927. 10.3389\/fnins.2023.1228927","journal-title":"Front Neurosci"},{"key":"ref142","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-024-04135-2","article-title":"A comprehensive review of membrane transporters and microRNA regulation in Alzheimer\u2019s disease","volume":"61","author":"Mishra S","year":"2024","unstructured":"Mishra S, Stany B, Das A, Kanagavel D, Vijayan M. A comprehensive review of membrane transporters and microRNA regulation in Alzheimer\u2019s disease. Mol Neurobiol. 2024, 61:8739-58. 10.1007\/s12035-024-04135-2","journal-title":"Mol Neurobiol"},{"key":"ref143","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11041113","article-title":"State of the art of microRNAs signatures as biomarkers and therapeutic targets in Parkinson\u2019s and Alzheimer\u2019s diseases: a systematic review and meta-analysis","volume":"11","author":"Zotarelli-Filho IJ","year":"2023","unstructured":"Zotarelli-Filho IJ, Mogharbel BF, Irioda AC, et al.. State of the art of microRNAs signatures as biomarkers and therapeutic targets in Parkinson\u2019s and Alzheimer\u2019s diseases: a systematic review and meta-analysis. Biomedicines. 2023, 11:10.3390\/biomedicines11041113","journal-title":"Biomedicines"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/428261-insights-from-a-scoping-review-and-bibliometric-analysis-of-trends-and-advances-in-biomarker-research-the-role-of-micrornas-in-cognitive-decline-across-neurodegenerative-diseases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T14:46:21Z","timestamp":1764600381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/428261-insights-from-a-scoping-review-and-bibliometric-analysis-of-trends-and-advances-in-biomarker-research-the-role-of-micrornas-in-cognitive-decline-across-neurodegenerative-diseases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":143,"URL":"https:\/\/doi.org\/10.7759\/cureus.98237","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,1]]}}}